Form 4 for TXG 10x Genomics, Inc.
Accepted 2021-09-03 00:00:00 ET · period of report 2021-09-01 · accession 0001209191-21-054899 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-09-03 | 2021-09-01 | TXG | Hindson Benjamin J. | See Remarks, Dir | M - OptEx | $5.04 | +41.7K | 88.8K | +88% | +$210.0K |
| DM | 2021-09-03 | 2021-09-01 | TXG | Hindson Benjamin J. | See Remarks, Dir | S - Sale+OE | $177.51 | -41.7K | 77.5K | -35% | -$7.40M |
| D | 2021-09-03 | 2021-09-01 | TXG | Hindson Benjamin J. | See Remarks, Dir | M - OptEx | $0.00 | -41.7K | 102.8K | -29% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2021-09-01 | M | A | 41,666 | $5.04 | 88,783 | D | — | — | |
| 2 | Common | Class A Common Stock | 2021-09-01 | S | D | 1,049 | $174.39 | 87,734 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $174.14 to $175.01. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 3 | Common | Class A Common Stock | 2021-09-01 | S | D | 2,728 | $175.69 | 85,006 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $175.14 to $176.135. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 4 | Common | Class A Common Stock | 2021-09-01 | S | D | 628 | $179.20 | 47,117 | D | — | — | (F7) This transaction was executed in multiple trades at prices ranging from $179.14 to $179.31. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 5 | Common | Class A Common Stock | 2021-09-01 | S | D | 21,145 | $177.72 | 56,331 | D | — | — | (F5) This transaction was executed in multiple trades at prices ranging from $177.14 to $178.13. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 6 | Common | Class A Common Stock | 2021-09-01 | S | D | 8,586 | $178.56 | 47,745 | D | — | — | (F6) This transaction was executed in multiple trades at prices ranging from $178.14 to $179.13. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 7 | Common | Class A Common Stock | 2021-09-01 | S | D | 7,530 | $176.65 | 77,476 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $176.14 to $177.12. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 8 | Derivative | Stock Option (right to buy) | 2021-09-01 | M | D | 41,666 | $0.00 | 102,782 | D | $5.04 · — to 2028-11-02 | 41,666 Class A Common Stock | (F8) This option, originally for 175,000 shares, of which 72,218 shares have been exercised, vested as to one forty-eighth of the shares on October 1, 2018 and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. |